Front Row Advisors’s Repligen RGEN Stock Holding History

Front Row Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98K	Hold	12	–	–	﹤0.01%	513
2026 Q1	$1.41K	Hold	12	–	–	﹤0.01%	520
2025 Q4	$1.97K	Hold	12	–	–	﹤0.01%	487
2025 Q3	$1.6K	Sell	12 -6	-33%	-$729	﹤0.01%	497
2025 Q2	$2.24K	Sell	18 -12	-40%	-$1.53K	﹤0.01%	468
2025 Q1	$3.82K	Hold	30	–	–	﹤0.01%	423
2024 Q4	$4.32K	Hold	30	–	–	﹤0.01%	416
2024 Q3	$4.46K	Hold	30	–	–	﹤0.01%	415
2024 Q2	$3.78K	Hold	30	–	–	﹤0.01%	776
2024 Q1	$5.52K	Hold	30	–	–	﹤0.01%	707
2023 Q4	$5.39K	Hold	30	–	–	﹤0.01%	371
2023 Q3	$4.77K	Hold	30	–	–	﹤0.01%	682
2023 Q2	$4K	Hold	30	–	–	﹤0.01%	720
2023 Q1	$5K	Buy	+30	New	+$5.35K	﹤0.01%	684

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Front Row Advisors's RGEN Position: Q2 2026 in Review

Front Row Advisors held its Repligen (RGEN) position steady in Q2 2026 at 12 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

Front Row Advisors first reported a position in RGEN in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.52K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Front Row Advisors held 12 shares of Repligen worth $1.98K as of Q2 2026.
Front Row Advisors left its Repligen share count unchanged in Q2 2026.
Repligen made up ﹤0.01% of Front Row Advisors's portfolio in Q2 2026, its #513 holding.
Front Row Advisors first reported a position in Repligen in Q1 2023 and has held it in 14 quarters since.
Front Row Advisors's Repligen position peaked at $5.52K in Q1 2024.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.